NexImmune
is a Maryland-based clinical-stage biotechnology company that researches and develops targeted cell-based immunotherapies for the treatment of cancer... Read moreNexImmune
is a Maryland-based clinical-stage biotechnology company that researches and develops targeted cell-based immunotherapies for the treatment of cancer... Read more
2011
PublicIndependent CompanyNASDAQNEXI
News
Aug 30, 2024
The Business Journals: Washington, D.C.
NexImmune: NexImmune moves forward with wind-down process
Apr 16, 2024
Marketscreener
NexImmune: NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb 06, 2024
BioSpace
NexImmune: NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Dec 26, 2023
The Business Journals
NexImmune: NexImmune's future in limbo as Gaithersburg biotech extends liquidation vote
Dec 01, 2023
MarketScreener
NexImmune: Neximmune : Failure to Satisfy Listing Rule - Form 8-K
Nov 17, 2023
Marketscreener
NexImmune: NexImmune, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov 09, 2023
The Business Journals: Baltimore
NexImmune: Gaithersburg biotech prepares to shut down, lay off 'substantially all' employees
Oct 24, 2023
Yahoo
NexImmune: NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
Oct 18, 2023
BioSpace
NexImmune: NexImmune Announces 1-for-25 Reverse Stock Split
Sep 01, 2023
Pharamceutical Technology
NexImmune: NexImmune to lay off over half of its employees
NexImmune Competitors
1
2
3
4
5
6
7
8
9
10